» Articles » PMID: 35467275

Aptasensors for Cancerous Exosome Detection

Overview
Specialty Molecular Biology
Date 2022 Apr 25
PMID 35467275
Authors
Affiliations
Soon will be listed here.
Abstract

Cancerous exosomes that carry multiple biomarkers are attractive targets for the early diagnosis and therapy of cancer. As one of the powerful molecular recognition tools, aptamers with excellent binding affinity and specificity toward biomarkers have been exploited to construct various aptamer-based biosensors (aptasensors) for exosome detection. Here, we review recent advances in aptasensors for the detection of cancerous exosomes. We first discuss the importance and potential of cancerous exosomes in cancer diagnosis and then summarize some conventional aptasensors from the perspective of biomarker recognition and signal collection strategies. Finally, we comment on the outlook for aptasensor research and new directions for cancerous exosome detection.

Citing Articles

Known and unknown: Exosome secretion in tumor microenvironment needs more exploration.

Huang M, Ji J, Xu X, Jin D, Wu T, Lin R Genes Dis. 2024; 12(1):101175.

PMID: 39524543 PMC: 11550746. DOI: 10.1016/j.gendis.2023.101175.


From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment.

Koelsch N, Manjili M Int J Mol Sci. 2023; 24(15).

PMID: 37569461 PMC: 10419122. DOI: 10.3390/ijms241512086.

References
1.
Leffall Jr L . Early diagnosis of colorectal cancer. CA Cancer J Clin. 1974; 24(3):152-9. DOI: 10.3322/canjclin.24.3.152. View

2.
Ranjan R, Esimbekova E, Kratasyuk V . Rapid biosensing tools for cancer biomarkers. Biosens Bioelectron. 2016; 87:918-930. DOI: 10.1016/j.bios.2016.09.061. View

3.
Majumdar D, Peng X, Shin D . The medicinal chemistry of theragnostics, multimodality imaging and applications of nanotechnology in cancer. Curr Top Med Chem. 2010; 10(12):1211-26. DOI: 10.2174/156802610791384171. View

4.
Novak D, Utikal J . New Biomarkers in Cancers. Cancers (Basel). 2021; 13(4). PMC: 7916116. DOI: 10.3390/cancers13040708. View

5.
Nassar F, Nasr R, Talhouk R . MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction. Pharmacol Ther. 2016; 172:34-49. DOI: 10.1016/j.pharmthera.2016.11.012. View